These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16445608)

  • 1. A decreasing incidence of ovarian carcinoma in Israel.
    Menczer J; Liphshitz I; Barchana M
    Int J Gynecol Cancer; 2006; 16(1):41-4. PubMed ID: 16445608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of borderline ovarian tumors in Israel: a population-based study.
    Iscovich J; Shushan A; Schenker JG; Paltiel O
    Cancer; 1998 Jan; 82(1):147-51. PubMed ID: 9428491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline ovarian tumors in Finland: epidemiology and familial occurrence.
    Auranen A; Grénman S; Mäkinen J; Pukkala E; Sankila R; Salmi T
    Am J Epidemiol; 1996 Sep; 144(6):548-53. PubMed ID: 8797514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood and adolescent ovarian malignant tumors in Israel. A nationwide study.
    Menczer J; Sadetzki S; Murad H; Barda G; Andreev H; Barchana M
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):813-7. PubMed ID: 10535348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations.
    Barchana M; Liphshitz I; Rozen P
    Fam Cancer; 2004; 3(3-4):207-14. PubMed ID: 15516843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
    Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
    Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Michaan N; Gortzak-Uzan L; Grisario D; Laskov I
    Int J Gynaecol Obstet; 2018 Aug; 142(2):176-181. PubMed ID: 29742279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Trends in the Incidence and Mortality of Ovarian Cancer in Ireland, Northern Ireland, and Israel, 1994-2013.
    Keinan-Boker L; Silverman BG; Walsh PM; Gavin AT; Hayes C
    Int J Gynecol Cancer; 2017 Oct; 27(8):1628-1636. PubMed ID: 28704323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran.
    Arab M; Khayamzadeh M; Hashemi M; Hosseini M; Tabatabaeefar M; Anbiaee R; Anvari N; Ebrahimi M; Akbari ME
    Arch Iran Med; 2010 May; 13(3):203-8. PubMed ID: 20433224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence rate of ovarian cancer in Iran in comparison with developed countries.
    Arab M; Khayamzadeh M; Tehranian A; Tabatabaeefar M; Hosseini M; Anbiaee R; Golfam F; Akbari ME
    Indian J Cancer; 2010; 47(3):322-7. PubMed ID: 20587911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing lung cancer incidence among Israeli Arab men reflects a change in the earlier paradox of low incidence and high smoking prevalence.
    Tarabeia J; Green MS; Barchana M; Baron-Epel O; Ifrah A; Fishler Y; Nitzan-Kaluski D
    Eur J Cancer Prev; 2008 Aug; 17(4):291-6. PubMed ID: 18562951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage at diagnosis of ovarian cancer in the United States, 1992-1997.
    Goodman MT; Correa CN; Tung KH; Roffers SD; Cheng Wu X; Young JL; Wilkens LR; Carney ME; Howe HL
    Cancer; 2003 May; 97(10 Suppl):2648-59. PubMed ID: 12733130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian cancer in Israel, 1960-1989].
    Mor-Yosef S; Avraham R; Schenker JG
    Harefuah; 1997 Feb; 132(3):153-5, 240. PubMed ID: 9154717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer incidence and survival in Korea: 1993-2002.
    Chung HH; Hwang SY; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
    Int J Gynecol Cancer; 2007; 17(3):595-600. PubMed ID: 17300678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
    Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
    Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in Israeli Jewish survivors of World War II.
    Keinan-Boker L; Vin-Raviv N; Liphshitz I; Linn S; Barchana M
    J Natl Cancer Inst; 2009 Nov; 101(21):1489-500. PubMed ID: 19861305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
    Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
    BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.